IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.271
NA - Nord America 11.939
EU - Europa 4.535
SA - Sud America 1.664
AF - Africa 224
Continente sconosciuto - Info sul continente non disponibili 161
OC - Oceania 65
AN - Antartide 2
Totale 42.861
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 16.371
US - Stati Uniti d'America 11.453
CN - Cina 3.333
HK - Hong Kong 2.531
IT - Italia 2.166
BR - Brasile 1.211
VN - Vietnam 737
GB - Regno Unito 680
FR - Francia 594
BD - Bangladesh 349
DE - Germania 326
IN - India 275
CA - Canada 248
AR - Argentina 180
MX - Messico 139
NL - Olanda 132
ID - Indonesia 113
ZA - Sudafrica 89
TR - Turchia 86
FI - Finlandia 83
EC - Ecuador 70
ES - Italia 65
JP - Giappone 65
RU - Federazione Russa 59
UA - Ucraina 59
AU - Australia 57
CO - Colombia 52
IQ - Iraq 50
PL - Polonia 50
SA - Arabia Saudita 47
CZ - Repubblica Ceca 39
CL - Cile 35
PY - Paraguay 34
PK - Pakistan 33
SE - Svezia 33
PE - Perù 32
MD - Moldavia 29
UZ - Uzbekistan 28
VE - Venezuela 28
PH - Filippine 27
EE - Estonia 25
MY - Malesia 23
CH - Svizzera 22
CR - Costa Rica 21
MA - Marocco 21
BG - Bulgaria 19
JM - Giamaica 19
LT - Lituania 19
NP - Nepal 17
AT - Austria 16
BE - Belgio 16
DZ - Algeria 16
KR - Corea 16
TH - Thailandia 16
RO - Romania 15
TN - Tunisia 15
EG - Egitto 14
IL - Israele 14
TW - Taiwan 14
UY - Uruguay 14
BH - Bahrain 12
JO - Giordania 12
KE - Kenya 12
KZ - Kazakistan 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
DO - Repubblica Dominicana 9
HU - Ungheria 9
KW - Kuwait 9
SI - Slovenia 9
AL - Albania 8
OM - Oman 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
HN - Honduras 7
IE - Irlanda 7
IR - Iran 7
LB - Libano 7
PT - Portogallo 7
RS - Serbia 7
BO - Bolivia 6
GT - Guatemala 6
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
KH - Cambogia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
CI - Costa d'Avorio 4
DM - Dominica 4
GA - Gabon 4
NI - Nicaragua 4
QA - Qatar 4
SN - Senegal 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 42.617
Salva come PNG Salva come JPEG
Città #
San Jose 3.420
Hong Kong 2.515
Ashburn 2.333
Singapore 2.151
Rome 1.523
Hefei 1.203
Council Bluffs 774
Boardman 707
Beijing 688
Columbus 617
London 557
Lauterbourg 525
Dallas 482
Shanghai 415
Santa Clara 328
Ho Chi Minh City 272
Los Angeles 180
New York 171
Hanoi 144
San Francisco 138
Munich 134
São Paulo 130
Seattle 90
Pune 88
Toronto 87
Mexico City 86
Amsterdam 69
Washington 65
Rio de Janeiro 52
Turku 50
Johannesburg 47
Milan 47
Tokyo 47
Warsaw 46
Montreal 44
Frankfurt am Main 43
Brooklyn 42
Chicago 41
Orem 39
Chennai 37
Brno 34
Naples 34
Da Nang 33
Melbourne 32
Helsinki 31
Las Vegas 31
Tashkent 28
Atlanta 27
Phoenix 26
St Louis 25
Belo Horizonte 24
Guayaquil 24
Buenos Aires 23
Manchester 23
Stockholm 23
Thái Bình 23
Boston 22
Riyadh 22
Baghdad 21
Buffalo 21
Quito 21
Haiphong 20
Hangzhou 20
Asunción 19
Biên Hòa 19
Brasília 18
Guangzhou 18
Istanbul 18
Porto Alegre 18
San José 18
Charlotte 17
Denver 17
New Delhi 17
Palermo 17
Ankara 16
Curitiba 16
Ribeirão Preto 16
Secaucus 16
Jakarta 15
Jeddah 15
Lima 15
Manaus 15
Boydton 14
West Jordan 14
Burgas 13
Hanover 13
Poplar 13
Turin 13
Bologna 12
Can Tho 12
Canberra 12
Hasselt 12
Madrid 12
Mumbai 12
Osasco 12
Philadelphia 12
Salvador 12
Bangkok 11
Bogotá 11
Cleveland 11
Totale 21.556
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 304
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 277
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 261
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 256
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 254
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 251
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 250
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 244
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 244
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 243
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 242
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 240
Early impairment of food intake in patients newly diagnosed with cancer 237
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 237
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 237
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 235
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 234
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 234
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 229
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 226
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 226
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 225
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 225
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 225
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 224
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 221
Premetastatic niche: ready for new therapeutic interventions? 220
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 220
Prevention of radiotherapy-induced emesis 220
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 218
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 218
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 217
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 216
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 215
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 213
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 210
Docetaxel induced pericardial effusion 208
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 205
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 205
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 204
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 203
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 198
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 194
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 193
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 180
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 170
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 168
A giant sarcoma of the parotid gland: A case report and review of the literature 166
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 159
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 158
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 157
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 156
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 149
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 145
'Old' and 'new' drugs for the treatment of cancer pain 144
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 142
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 141
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 140
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 139
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 138
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 135
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 135
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 134
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 134
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 134
[Neoplastic hypercalcemia]. 133
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 133
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 132
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 132
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 130
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 130
Colorectal carcinomas and PTEN/MMAC1 gene mutations 129
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 129
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 129
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 128
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 128
Biological effects of cabozantinib on bone microenvironment 128
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 127
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 127
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 126
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 126
An omental mass: any hypothesis? 125
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. 124
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 123
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 121
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 121
Azygo-tracheal fistula in a complete implantable central venous system 120
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 119
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 119
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 119
Atypical chronic head and neck pain: don't forget Eagle's syndrome 118
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 118
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 116
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 116
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 116
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 116
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 115
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 115
Large abdominal mass in Crohn's disease 114
Totale 17.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 311.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 311.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 5 8 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/202618.923 1.669 739 1.263 2.160 674 1.141 4.822 1.601 1.537 1.708 844 765
2026/20271.831 401 1.430 0 0 0 0 0 0 0 0 0 0
Totale 42.861